[1]Shen ZX, Chen GQ, Ni JH, et al. Use of arsenic trioxide (As2O3)in th e treatment of acute promyelocytic leukemia (APL):Ⅱ.clinical efficacy and pharmacokinetics in relapsed patients[J].Blood,1997,89:3354-3360. [2]Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treat ment of acute promyelocytic leukemia with arsenic trioxide[J].New Engl J Med,1998,339(19):1341-1348. [3]Akao Y, Nakagawa Y,Akiyama K. Arsenic trioxide induces apoptosisin n euroblastoma cell lines through the activation of caspase 3 in vitro[J] .FEBS Lett, 1999,455(1~2):59-62. [4]Look AT. Arsenic and apoptosis in the treatment of acute promyelocyt ic leukemia[J].J Natl Cancer Inst,1998,90(2):86-88. [5]Wang ZG, Rivi R, Delva L, et al .Arsenic trioxide and melarsoprol in duce programmed cell death in myeloid leukemia cell lines and function in a PML and PMLRARα independent manner[J].Blood,1998,92:1497-1504 . [6]王剑明,邹倩,邹声泉.Bcl2基因在阻塞性黄疸大鼠肝组织细胞凋亡中作用的 研究[J].世界华人消化杂志,1999,7(12):1035-1037. [7]乔庆,吴金生,张静,等.凋亡相关基因bcl2,bax在人类大肠腺癌中的表达意 义[J].世界华人消化杂志,1999,7(11):936-938. [8]李雪莉,郝远瑞,邹建湘,等.Cmyc,Bcl2与胃癌生物学行为和细胞凋亡[J ].新消化病杂志,1997,5(12):773-774. [9]郭琳琅,曹长安,王友顺,等.Bcl2及相关蛋白bax在肝脏良恶性病变中的表 达[J].新消化病杂志,1997,5(10):655-656. [10]Konig A,Wrazkl Z, Warrell RP, et al. Comparative activity of melars oprol and arsenic trioxide in chronic Bcell leukemia lines[J].Blood,1 997,90:562-570. [11]Chen GQ, Zhu J,Shi XG, et al.In vitro studies on cellular and molec ular mechanisms of arsenic trioxide (As2O3)in the treatment of acute pr omyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulati on of Bcl2 expression and modulation of PMLRAR alpha /PML proteins[ J].Blood,1996,88(3):1052-1061. [12]刘铁夫,梁桃.三氧化二砷影响肝癌细胞系Hep201凋亡的研究[J].黑龙江医学 ,2001,25(2):81-82. [13]刘琳,秦叔逵,陈惠英,等.三氧化二砷选择性诱导人肝癌细胞凋亡及相关基 因的实验研究[J].中华肝脏病杂志,2000,8(6):367-369. [14]陈惠英,刘文虎,秦叔逵.三氧化二砷对肝癌细胞株凋亡的诱导作用[J].世界 华人消化杂志,2000,8(5):532-535. [15]徐洪雨,高媛媛,武俏丽,等.三氧化二砷抑制人肝癌细胞株增殖和诱导凋亡 作用[J].世界华人消化杂志,2000,8(11):1233-1237. [16]刘冰熔.核转录因子NFκB——肿瘤基因治疗的新焦点[J].国外医学免疫学分 册,2001,24(3):129-132. [17]Mahieux R, P.. |